US 11,970,448 B2
Monomers capable of dimerizing in an aqueous solution, and methods of using same
Francis Barany, New York, NY (US); Maneesh Pingle, New York, NY (US); Donald E. Bergstrom, West Lafayette, IN (US); Sarah F. Giardina, New York, NY (US); and Lee Daniel Arnold, Mt. Sinai, NY (US)
Assigned to CORNELL UNIVERSITY, Ithaca, NY (US); and PURDUE RESEARCH FOUNDATION, West Lafayette, IN (US)
Filed by CORNELL UNIVERSITY, Ithaca, NY (US); and PURDUE RESEARCH FOUNDATION, West Lafayette, IN (US)
Filed on Jul. 15, 2020, as Appl. No. 16/929,528.
Application 16/929,528 is a continuation of application No. 14/110,056, abandoned, previously published as PCT/US2012/032809, filed on Apr. 9, 2012.
Claims priority of provisional application 61/473,093, filed on Apr. 7, 2011.
Prior Publication US 2020/0354319 A1, Nov. 12, 2020
This patent is subject to a terminal disclaimer.
Int. Cl. C07D 211/26 (2006.01); C07D 405/06 (2006.01); C07D 409/06 (2006.01); C07D 491/107 (2006.01); C07F 5/02 (2006.01); C07F 5/04 (2006.01)
CPC C07D 211/26 (2013.01) [C07D 405/06 (2013.01); C07D 409/06 (2013.01); C07D 491/107 (2013.01); C07F 5/025 (2013.01); C07F 5/04 (2013.01)] 3 Claims
 
1. A therapeutic composition comprising a first monomer selected from the group consisting of:

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry
and
a second monomer selected from the group consisting of:

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry
and
pharmaceutically acceptable salts, stereoisomers, or hydrates thereof.